trehalose has been researched along with Epilepsy Progressive Myoclonic 2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Abramo, F; Battini, R; Della Vecchia, S; Landi, S; Licitra, R; Marchese, M; Mero, S; Nardi, G; Ogi, A; Ratto, GM; Santorelli, FM; Sicca, F | 1 |
Ganesh, S; Sinha, P; Verma, B | 1 |
Ballester, MI; Berthier, A; García-Cabrero, AM; Heredia, M; Payá, M; Sánchez, MP; Sanz, P; Serratosa, JM | 1 |
3 other study(ies) available for trehalose and Epilepsy Progressive Myoclonic 2
Article | Year |
---|---|
Trehalose Treatment in Zebrafish Model of Lafora Disease.
Topics: Animals; Lafora Disease; Mutation; Protein Tyrosine Phosphatases, Non-Receptor; Seizures; Trehalose; Ubiquitin-Protein Ligases; Zebrafish | 2022 |
Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
Topics: Animals; Autophagy; Brain; Calcium-Binding Proteins; Disease Models, Animal; Disease Susceptibility; Endoplasmic Reticulum Stress; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Glucans; Inflammation; Lafora Disease; Membrane Proteins; Mice, Knockout; Microfilament Proteins; Nerve Tissue Proteins; Pentylenetetrazole; Protein Tyrosine Phosphatases, Non-Receptor; Seizures; Trehalose; Ubiquitin-Protein Ligases | 2021 |
Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.
Topics: Animals; Brain; Disease Models, Animal; Fluorescent Antibody Technique; Gliosis; Glucans; Hippocampus; Inclusion Bodies; Lafora Disease; Metformin; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neuropsychological Tests; Phenylbutyrates; Protein Aggregates; Trehalose; Ubiquitin-Protein Ligases; Ubiquitinated Proteins | 2016 |